DRRX and BHC Related Headlines
Go Back- Bausch Health completes DURECT acquisition for $63 million
- Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
- Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
- Bausch Health to acquire DURECT for $63 million upfront
- Bausch Health to acquire DURECT for $63 million upfront
- Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
- Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
DRRX and BHC Related Press Releases
Go Back- Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
- Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
- Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
- Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
